Taysha Gene Therapies, Inc. TSHA Quick ratio
Quick ratio at other companies
Other financials
Where this comes from
Calculated from Taysha Gene Therapies, Inc.’s reported figures.
Based on the most recent quarter.
The official record: Taysha Gene Therapies, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Taysha Gene Therapies, Inc.'s quick ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Taysha Gene Therapies, Inc.'s quick ratio?
- Taysha Gene Therapies, Inc. (TSHA) reported quick ratio of 14× in Q1 2026.
- How has Taysha Gene Therapies, Inc.'s quick ratio changed year-over-year?
- Taysha Gene Therapies, Inc.'s quick ratio increased by 162.4% year-over-year, from 5.4× to 14×.
- What is the long-term trend for Taysha Gene Therapies, Inc.'s quick ratio?
- Over 5 years (2020 to 2025), Taysha Gene Therapies, Inc.'s quick ratio has grown at a -19.5% compound annual growth rate (CAGR), from 36.2× to 12.2×.
- What does quick ratio mean?
- Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.